Should you hold GW Pharmaceuticals (gwph) stock?
The consensus among Wall Street research analysts is that investors should "hold" GW Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares.
Is jazz paying $200 for gwph stock?
This will have JAZZ paying a 50% premium over the stock’s closing price on Tuesday. The company is using a mix of cash and stock to complete this transaction. This will have it paying $200 in cash and $20 in JAZZ stock for each share of GWPH stock.
Why is GW Pharmaceuticals stock soaring 77% in the first half?
Why Marijuana Stock GW Pharmaceuticals Soared 77% in the First Half of 2019 Beth McKenna | Jul 7, 2019 A hot cannabis sector and better-than-expected initial U.S. sales of its CBD-based drug, Epidiolex, lit a fire under this biotech's stock.
Does GW Pharmaceuticals stock pay dividends?
GW Pharmaceuticals does not currently pay a dividend. Dividend Growth. GW Pharmaceuticals does not have a long track record of dividend growth. Previous Next . 1.7 Company Ownership. Insider Buying vs. Insider Selling. In the past three months, GW Pharmaceuticals insiders have not sold or bought any company stock.
See more
What happen to GWPH?
Jazz Pharmaceuticals (NASDAQ:JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH). GW shareholders gave the thumbs up to the deal last month. With the acquisition, Jazz gains access to GW's cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 2020.
Who bought GWPH stock?
Jazz PharmaceuticalsOn Friday, shareholders of GW Pharmaceuticals (GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (JAZZ 2.58%), both companies announced in a joint press release.
Should I sell my GW Pharmaceuticals stock?
GW Pharmaceuticals PLC(GWPH-Q) Rating A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Why is GWPH stock dropping?
Shares of GW Pharmaceuticals PLC gwph slumped 12% Friday, after the company swung to a loss in the second quarter, hurt by the effect of the coronavirus pandemic.
Did Jazz Pharmaceuticals buy GWPH?
DUBLIN , May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
Does GW Pharmaceuticals still exist?
In May 2013, the company became dual-listed on the NASDAQ and AIM. In 2014, the company made a deal with New York to develop clinical trials using cannabidiol (CBD) to treat children who suffer from seizures and other medical complications. In May 2021, Jazz Pharmaceuticals acquired the company.
How were GW Pharmaceuticals' earnings last quarter?
GW Pharmaceuticals plc (NASDAQ:GWPH) released its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36)...
Who are GW Pharmaceuticals' key executives?
GW Pharmaceuticals' management team includes the following people: Mr. Justin D. Gover , CEO & Exec. Director (Age 50, Pay $1.19M) ( LinkedIn Pr...
What is Justin Gover's approval rating as GW Pharmaceuticals' CEO?
14 employees have rated GW Pharmaceuticals CEO Justin Gover on Glassdoor.com . Justin Gover has an approval rating of 80% among GW Pharmaceuticals...
Who are some of GW Pharmaceuticals' key competitors?
Some companies that are related to GW Pharmaceuticals include Royalty Pharma (RPRX) , MERCK Kommanditgesellschaft auf Aktien (MKGAF) , Takeda Ph...
What other stocks do shareholders of GW Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other GW Pharmaceuticals investors own include (CGC) , NVIDIA...
What is GW Pharmaceuticals' stock symbol?
GW Pharmaceuticals trades on the NASDAQ under the ticker symbol "GWPH."
What is GW Pharmaceuticals' stock price today?
One share of GWPH stock can currently be purchased for approximately $218.96.
How much money does GW Pharmaceuticals make?
GW Pharmaceuticals has a market capitalization of $6.86 billion and generates $311.33 million in revenue each year. The biopharmaceutical company e...
How many employees does GW Pharmaceuticals have?
GW Pharmaceuticals employs 1,161 workers across the globe.
About GW Pharmaceuticals
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas.
GW Pharmaceuticals (NASDAQ:GWPH) Frequently Asked Questions
GW Pharmaceuticals plc (NASDAQ:GWPH) released its quarterly earnings results on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.63) by $0.27.